Diabetes Care Devices - Europe | Statista Market Forecast

In Europe, revenue in the Diabetes Care Devices market market is projected to reach US$6.63bn in 2024.
It is expected that revenue will exhibit an annual growth rate (CAGR 2024-2029) of 12.08%, leading to a market volume of US$11.73bn by 2029.
When compared globally, the majority of revenue will be generated the United States, with a forecasted figure of US$11.71bn in 2024.
In Europe, there is a growing demand for innovative diabetes care devices as patients increasingly seek integrated technology solutions for better disease management.

Definition:
The Diabetes Care Devices market, a medical technology market, includes medical devices used in the management and treatment of diabetes. These devices range from blood glucose meters and continuous glucose monitoring systems to insulin pumps, insulin pens, and other related accessories. It is important to note that the market does not include pharmaceutical products used in the treatment of diabetes, such as insulin and oral hypoglycemic agents.

Additional information:
Market values represent revenues paid to primary vendors at manufacturer price level either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), enterprises (B2B), and governments (B2G). Revenues are allocated to the country where the money is spent.

Key players in the market include Medtronic, Abbott Laboratories, and Roche Diagnostics. Further information on the key players can be found in the Market Shares boxes.

Blood glucose monitoring devices
Insulin delivery devices

Diabetes drugs
Diabetes supplements

The Diabetes Care Devices Market in Europe is witnessing considerable growth, fueled by factors such as technological advancements, increased focus on preventive healthcare, and rising diabetes prevalence, all enhancing the demand for innovative diabetes management solutions.

Customer preferences: Consumers in Europe are increasingly prioritizing personalized diabetes management solutions, reflecting a shift towards tailored healthcare experiences. This trend is driven by the rise of health-conscious millennials and Gen Z, who favor smart devices that integrate seamlessly with their digital lifestyles. Furthermore, the growing emphasis on holistic health is prompting greater interest in connected health apps that offer real-time data sharing with healthcare providers. As awareness of diabetes management improves, there's a heightened demand for user-friendly, innovative technologies that support proactive health decisions.

Trends in the market: In Europe, the Diabetes Care Devices Market is experiencing a surge in demand for advanced glucose monitoring systems, including continuous glucose monitors (CGMs) that provide real-time data. There is also an increasing integration of artificial intelligence in diabetes management apps, enhancing personalization and predictive analytics. Additionally, the focus on preventative healthcare is driving interest in wearable devices that track not only glucose levels but also lifestyle factors. These trends are significant as they empower patients to take control of their health, while industry stakeholders must adapt their offerings to meet the evolving needs of a more tech-savvy consumer base.

Local special circumstances: In Europe, the Diabetes Care Devices Market is shaped by diverse factors, including varying healthcare systems and regulatory environments across countries. The European Union's stringent regulations ensure high safety and efficacy standards, fostering trust in advanced technologies. Additionally, cultural attitudes towards health and wellness influence consumer adoption; for instance, Nordic countries prioritize preventative care, driving interest in integrated health solutions. Furthermore, the rise of digital health literacy among European populations encourages the uptake of smart diabetes management devices, transforming patient engagement and self-care.

Underlying macroeconomic factors: The Diabetes Care Devices Market in Europe is significantly influenced by macroeconomic factors such as healthcare funding, economic stability, and demographic trends. Countries with robust healthcare systems and strong government investment in diabetes management technologies are witnessing accelerated market growth. The rising prevalence of diabetes, coupled with an aging population, amplifies the demand for innovative care solutions. Furthermore, fiscal policies promoting health technology adoption and reimbursement frameworks enhance market accessibility. Additionally, global economic trends, such as inflation and supply chain dynamics, can impact the affordability and availability of advanced diabetes care devices, shaping market performance across the region.

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Medical technology plays a role in the lives of everyone. It includes most of all, medical devices which simplify the prevention, diagnosis, and treatment of diseases and illnesses. The most well-known medical technology products are, among others, pacemakers, imaging instruments, dialysis machines, and implants. The global medical technology industry was worth over 567 billion U.S. dollars annually. Established centers of this industry include North America and Western Europe. The United States is home to the world’s largest medical technology companies. As of 2022, Abbott Laboratories had the largest global revenue at over 31.2 billion U.S. dollars. The main focus of devices manufactured by the Chicago-based company are diagnostics, cardiovascular, and diabetes care. Two other medtech companies that round off the top three largest companies –Medtronic and Johnson & Johnson – are both based in the United States. Although, industry trends show that Asia, and in particular China, is about to play a more prominent role in the years to come.